Mega, J.L., Braunwald, E., Wiviott, S.D., Bassand, J.P., Bhatt, D.L., Bode, C., et al. (2012) Rivaroxaban in Patients with a Recent Acute Coronary Syndrome. The New England Journal of Medicine, 366, 9-19.
http://dx.doi.org/10.1056/NEJMoa1112277

has been cited by the following article:

• TITLE: Prognosis of Patients with Acute Coronary Syndromes and Bleeding—The Importance of Routine Use of a Bleeding Risk Score

  AUTHORS: Alexandre de Matos Soeiro, Ricardo Cesar Campos Devezae Silva, Aline Siqueira Bossa, Cindel Nogueira Zullino, Tatiana de Carvalho Andreucci Torres Leal, Maria Carolina Feres de Almeida Soeiro, Carlos V. Serrano Jr., Múcio Tavares Oliveira Jr.

  KEYWORDS: Unstable Angina, Bleeding, Acute Myocardial Infarction

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.5 No.12, December 4, 2015

  ABSTRACT: Introduction: Recent studies showed relation between mortality and bleeding in acute coronary syndromes. Objective: The objective is to analyze the prognosis of patients with acute coronary syndromes with or without in-hospital major and/or minor bleedings. Methods: This was a pro-spective data bank analysis study with 546 patients (39 with bleeding (group I) and 507 without bleeding (group II)) with acute coronary syndromes included between May 2010 and May 2013. Besides, Mehran bleeding risk score was calculated to all patients. The primary endpoint was all causes of in-hospital death and combined events. Comparison between groups was made by Anova and Q-square. Multivariate analysis was determined by logistic regression and was considered significant when p p = 0.005) and combined events (35.9% vs 11.4%, p